Clinical Study

Low Serum Concentration of Obestatin as a Predictor of Mortality in Maintenance Hemodialysis Patients

Table 1

Comparison between subjects with lower and higher serum obestatin levels stratified by the median of obestatin in the study population ( ).

ObestatinObestatin for trend
≤7.12 ng/mL>7.12 ng/mL
( )( )

Demographic and clinical variables
 Age (years) 0.88
 Gender (men/women)168.1/31.955.3/44.70.023
 Dialysis vintage (months)228.0 (12.0–47.0)34.0 (20.0–54.0)0.21
 DM155.346.8 0.42
 History of CV disease151.151.10.99
 SBP (mm Hg) 0.75
 DBP (mm Hg) 0.75
 Kt/V 0.90
Dietary intake
 Energy intake (kcal/kg/d) 0.29
 Protein intake (g/kg/d) 0.14
 nPNA (g/kg/d) 0.30
Biochemical markers
 Albumin (g/L) 0.31
 Creatinine (µmol/L) 0.92
 Cholesterol (mmol/L) 0.46
 Transferrin (g/L) 0.98
 TLC (×103/mL) 0.15
 Hemoglobin (g/L) 0.92
 IL-6 (pg/mL)26.3 (3.3–11.6) 6.7 (3.3–10.9)0.79
 TNF-α (pg/mL)215.4 (9.0–32.9)25.5 (11.7–35.5)0.10
 Leptin (ng/mL)216.2 (5.6–68.0) 23.0 (5.5–93.1)0.49
 Obestatin (ng/mL)
Anthropometric measurements
 BMI (kg/m2) 0.22
 TSF (mm) 0.005
 MAC (cm) 0.014
 MAMC (cm) 0.22
Bioimpedance analysis
 ECW/TBW 0.56
 FMI (kg/m2) 0.027
 FFMI (kg/m2) 0.89
 Phase angle (°) 0.48

Continuous variables are expressed as mean ± SD or as median with 25th to 75th percentile shown in parentheses in cases of nonnormally distributed data, and categorical variables are expressed as a percentage.
Assessed by 2 test.
Compared by the nonparametric Mann-Whitney test.
DM: diabetes mellitus; CV: cardiovascular; SBP: predialysis systolic blood pressure; DBP: predialysis diastolic blood pressure; nPNA: normalized protein nitrogen appearance; TLC: total lymphocyte count; IL-6: interleukin-6; TNF-α: tumor necrosis factor-α; BMI: body mass index; TSF: triceps skinfold thickness; MAC: midarm circumference; MAMC: midarm muscle circumference calculated; ECW/TBW: extracellular water to total body water ratio; FMI: fat mass index; and FFMI: fat-free mass index.